demonstrated highly significant reduction of CD99 in severe/critical COVID-19, indicating the reduction of endothelial integrity and interference with transendothelial migration of monocytes, neutrophils, and T-cell recruitment (57). The gene discussed is CD99; the disease is COVID-19.